Stuart Johnson
Impact in
- Infectious Diseases top 0.01%
- Clostridium difficile and Clostridium perfringens research
- Viral gastroenteritis research and epidemiology
- Antimicrobial Resistance in Staphylococcus
-
- Nosocomial Infections in ICU
Papers in
-
- Clostridium difficile and Clostridium perfringens research 149
- Viral gastroenteritis research and epidemiology 41
- Antimicrobial Resistance in Staphylococcus 23
- Epidemiology 83
- Microscopic Colitis 71
- Co-authors
- Dale N. Gerding (94 shared papers)L. Clifford McDonald (7 shared papers)Susan P. Sambol (37 shared papers)Mark H. Wilcox (8 shared papers)Ciarán P. Kelly (6 shared papers)Vivian G. Loo (4 shared papers)Lance R. Peterson (14 shared papers)Stuart H. Cohen (2 shared papers)
- Journals
- Clinical Infectious Diseases (27 papers)Infection Control and Hospital Epidemiology (17 papers)Open Forum Infectious Diseases (10 papers)The Journal of Infectious Diseases (10 papers)Antimicrobial Agents and Chemotherapy (9 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Stuart Johnson
183 papers receiving 18.3k citations
Stuart Johnson's Hit Papers
Peers
Comparison fields: 5 of 160
- Infectious Diseases 16.3k
- Critical Care and Intensive Care Medicine 1.9k
- Gastroenterology 1.3k
- Epidemiology 7.8k
- Applied Microbiology and Biotechnology 245
Countries citing papers authored by Stuart Johnson
This map shows the geographic impact of Stuart Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Johnson more than expected).
Fields of papers citing papers by Stuart Johnson
This network shows the impact of papers produced by Stuart Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Johnson. The network helps show where Stuart Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 188 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Hit paper breakdown → | 2010 | 2298 |
| 2 | Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) Hit paper breakdown → | 2017 | 1927 |
| 3 | An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile Hit paper breakdown → | 2005 | 1564 |
| 4 | Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) Hit paper breakdown → | 2018 | 799 |
| 5 | Toxin B is essential for virulence of Clostridium difficile Hit paper breakdown → | 2009 | 591 |
| 6 | Clostridium Difficile-Associated Diarrhea and Colitis Hit paper breakdown → | 1995 | 510 |
| 7 | Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults Hit paper breakdown → | 2021 | 406 |
| 8 | Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials Hit paper breakdown → | 2014 | 400 |
| 9 | 1992 | 365 | |
| 10 | 1998 | 326 | |
| 11 | 2013 | 325 | |
| 12 | 1995 | 316 | |
| 13 | 2009 | 313 | |
| 14 | 1998 | 297 | |
| 15 | 2007 | 291 | |
| 16 | 2009 | 275 | |
| 17 | 1999 | 273 | |
| 18 | 1990 | 265 | |
| 19 | 1992 | 264 | |
| 20 | 2007 | 244 |
About Stuart Johnson
Stuart Johnson is a scholar working on Infectious Diseases, Epidemiology, Critical Care and Intensive Care Medicine, Surgery and Gastroenterology, having authored 188 papers that have together received 18.9k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (149 papers), Microscopic Colitis (71 papers), Viral gastroenteritis research and epidemiology (41 papers), Antimicrobial Resistance in Staphylococcus (23 papers), Nosocomial Infections in ICU (22 papers), Helicobacter pylori-related gastroenterology studies (16 papers), Gastrointestinal motility and disorders (9 papers) and Bacterial Identification and Susceptibility Testing (8 papers). The work is most often cited by research in Infectious Diseases (16.3k citations), Critical Care and Intensive Care Medicine (1.9k citations), Gastroenterology (1.3k citations), Epidemiology (7.8k citations) and Applied Microbiology and Biotechnology (245 citations). Stuart Johnson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Dale N. Gerding, L. Clifford McDonald, Susan P. Sambol, Mark H. Wilcox, Ciarán P. Kelly, Vivian G. Loo, Lance R. Peterson, Stuart H. Cohen, Kevin W. Garey and George Killgore. Their work appears in journals such as Clinical Infectious Diseases, Infection Control and Hospital Epidemiology, Open Forum Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.